Menoret A - Search Results

1

A high OXPHOS CD8 T cell subset is predictive of immunotherapy resistance in melanoma patients.

Li C, Phoon YP, Karlinsey K, Tian YF, Thapaliya S, Thongkum A, Qu L, Matz AJ, Cameron M, Cameron C, Menoret A, Funchain P, Song JM, Diaz-Montero CM, Tamilselvan B, Golden JB, Cartwright M, Rodriguez A, Bonin C, Vella A, Zhou B, Gastman BR. Li C, et al. Among authors: menoret a. J Exp Med. 2022 Jan 3;219(1):e20202084. doi: 10.1084/jem.20202084. Epub 2021 Nov 22. J Exp Med. 2022. PMID: 34807232 Free PMC article.

2

TGFbeta protein processing and activity through TCR triggering of primary CD8+ T regulatory cells.

Ménoret A, Myers LM, Lee SJ, Mittler RS, Rossi RJ, Vella AT. Ménoret A, et al. J Immunol. 2006 Nov 1;177(9):6091-7. doi: 10.4049/jimmunol.177.9.6091. J Immunol. 2006. PMID: 17056535

3

The oxazolidinone derivative locostatin induces cytokine appeasement.

Ménoret A, McAleer JP, Ngoi SM, Ray S, Eddy NA, Fenteany G, Lee SJ, Rossi RJ, Mukherji B, Allen DL, Chakraborty NG, Vella AT. Ménoret A, et al. J Immunol. 2009 Dec 1;183(11):7489-96. doi: 10.4049/jimmunol.0901414. Epub 2009 Nov 16. J Immunol. 2009. PMID: 19917702 Free PMC article.

4

Utilizing endoscopic technology to reveal real-time proteomic alterations in response to chemoprevention.

Nakanishi M, Ménoret A, Belinsky GS, Giardina C, Godman CA, Vella AT, Rosenberg DW. Nakanishi M, et al. Among authors: menoret a. Proteomics Clin Appl. 2007 Dec;1(12):1660-6. doi: 10.1002/prca.200700545. Proteomics Clin Appl. 2007. PMID: 21136663

5

Selective PGE(2) suppression inhibits colon carcinogenesis and modifies local mucosal immunity.

Nakanishi M, Menoret A, Tanaka T, Miyamoto S, Montrose DC, Vella AT, Rosenberg DW. Nakanishi M, et al. Among authors: menoret a. Cancer Prev Res (Phila). 2011 Aug;4(8):1198-208. doi: 10.1158/1940-6207.CAPR-11-0188. Epub 2011 May 16. Cancer Prev Res (Phila). 2011. PMID: 21576350 Free PMC article.

6

CD134 plus CD137 dual costimulation induces Eomesodermin in CD4 T cells to program cytotoxic Th1 differentiation.

Qui HZ, Hagymasi AT, Bandyopadhyay S, St Rose MC, Ramanarasimhaiah R, Ménoret A, Mittler RS, Gordon SM, Reiner SL, Vella AT, Adler AJ. Qui HZ, et al. Among authors: menoret a. J Immunol. 2011 Oct 1;187(7):3555-64. doi: 10.4049/jimmunol.1101244. Epub 2011 Aug 31. J Immunol. 2011. PMID: 21880986 Free PMC article.

7

The systemic and pulmonary immune response to staphylococcal enterotoxins.

Kumar S, Ménoret A, Ngoi SM, Vella AT. Kumar S, et al. Among authors: menoret a. Toxins (Basel). 2010 Jul;2(7):1898-912. doi: 10.3390/toxins2071898. Epub 2010 Jul 21. Toxins (Basel). 2010. PMID: 22069664 Free PMC article. Review.

8

Presensitizing with a Toll-like receptor 3 ligand impairs CD8 T-cell effector differentiation and IL-33 responsiveness.

Ngoi SM, St Rose MC, Menoret AM, Smith DE, Tovey MG, Adler AJ, Vella AT. Ngoi SM, et al. Proc Natl Acad Sci U S A. 2012 Jun 26;109(26):10486-91. doi: 10.1073/pnas.1202607109. Epub 2012 Jun 11. Proc Natl Acad Sci U S A. 2012. PMID: 22689946 Free PMC article.

9

Cytochrome b5 and cytokeratin 17 are biomarkers in bronchoalveolar fluid signifying onset of acute lung injury.

Ménoret A, Kumar S, Vella AT. Ménoret A, et al. PLoS One. 2012;7(7):e40184. doi: 10.1371/journal.pone.0040184. Epub 2012 Jul 6. PLoS One. 2012. PMID: 22792238 Free PMC article.

10

Differential proteomics identifies PDIA3 as a novel chemoprevention target in human colon cancer cells.

Ménoret A, Drew DA, Miyamoto S, Nakanishi M, Vella AT, Rosenberg DW. Ménoret A, et al. Mol Carcinog. 2014 Feb;53 Suppl 1:E11-22. doi: 10.1002/mc.21986. Epub 2012 Dec 19. Mol Carcinog. 2014. PMID: 23255428

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

77 results

Search Page